BR112023018942A2 - Formulações estáveis de indocianina verde - Google Patents

Formulações estáveis de indocianina verde

Info

Publication number
BR112023018942A2
BR112023018942A2 BR112023018942A BR112023018942A BR112023018942A2 BR 112023018942 A2 BR112023018942 A2 BR 112023018942A2 BR 112023018942 A BR112023018942 A BR 112023018942A BR 112023018942 A BR112023018942 A BR 112023018942A BR 112023018942 A2 BR112023018942 A2 BR 112023018942A2
Authority
BR
Brazil
Prior art keywords
indocyanine green
stable
formulations
green formulations
compositions
Prior art date
Application number
BR112023018942A
Other languages
English (en)
Portuguese (pt)
Inventor
Babak Sayah
Marina Laurent
Nicolas Lopez
Original Assignee
Provepharm Life Solutions
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provepharm Life Solutions filed Critical Provepharm Life Solutions
Publication of BR112023018942A2 publication Critical patent/BR112023018942A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112023018942A 2021-03-17 2022-03-14 Formulações estáveis de indocianina verde BR112023018942A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21305323 2021-03-17
PCT/EP2022/056445 WO2022194733A2 (en) 2021-03-17 2022-03-14 Stable formulations of indocyanine green

Publications (1)

Publication Number Publication Date
BR112023018942A2 true BR112023018942A2 (pt) 2023-10-10

Family

ID=75302475

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023018942A BR112023018942A2 (pt) 2021-03-17 2022-03-14 Formulações estáveis de indocianina verde

Country Status (6)

Country Link
US (1) US20240165275A1 (cg-RX-API-DMAC7.html)
EP (1) EP4308081A2 (cg-RX-API-DMAC7.html)
JP (1) JP7842776B2 (cg-RX-API-DMAC7.html)
CN (1) CN116997325B (cg-RX-API-DMAC7.html)
BR (1) BR112023018942A2 (cg-RX-API-DMAC7.html)
WO (1) WO2022194733A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119215199B (zh) * 2024-10-12 2025-12-09 石家庄四药有限公司 一种注射用吲哚菁绿的冻干工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509260A (ja) * 1993-04-20 1996-10-01 マリンクロット・メディカル・インコーポレイテッド 電圧感受性染料の安定化
FR2710060B1 (fr) 1993-09-17 1995-11-17 Rech Biolog Et Procédé de préparation de benz[e]indoles substitués de pureté élevée et leurs sels alcalins.
GB9712524D0 (en) 1997-06-16 1997-08-20 Nycomed Imaging As Method
US6944493B2 (en) 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
US8337809B2 (en) * 2006-09-11 2012-12-25 William Marsh Rice University Charge-assembled capsules for phototherapy
DE102007030403A1 (de) 2007-06-29 2009-01-08 Universität Bielefeld Verfahren zur Verbesserung der Photostabilität von Fluoreszenzfarbstoffen
JP5257971B2 (ja) 2007-10-25 2013-08-07 国立大学法人 千葉大学 胚性幹細胞から肝芽細胞を得る方法
CN103301482B (zh) 2013-06-27 2014-12-17 深圳先进技术研究院 两亲性三嵌段聚多肽载icg胶束及其制备方法
JP2015040185A (ja) 2013-08-21 2015-03-02 キヤノン株式会社 造影用組成物
JP6623479B2 (ja) 2015-02-08 2019-12-25 トンリ・バイオメディカル・カンパニー・リミテッド 脂質ナノ粒子及びその使用
CA3021809A1 (en) 2015-05-11 2016-11-17 Dicronis Sagl Compositions for circulatory system visualization
DK3383436T3 (da) 2015-12-01 2023-11-20 Dishman Carbogen Amcis Ltd Forbedret fremgangsmåde til fremstilling af indocyaningrønt
US20190337896A1 (en) 2018-05-02 2019-11-07 Biophore India Pharmaceuticals Pvt. Ltd. PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN)
WO2020240514A1 (en) * 2019-05-30 2020-12-03 Leiutis Pharmaceuticals Pvt, Ltd. Stable formulations of indocyanine green
CN111514125B (zh) * 2020-05-26 2021-03-23 中山万汉制药有限公司 含有喹诺酮类化合物与依地酸类化合物的组合物

Also Published As

Publication number Publication date
CN116997325A (zh) 2023-11-03
EP4308081A2 (en) 2024-01-24
US20240165275A1 (en) 2024-05-23
JP7842776B2 (ja) 2026-04-08
WO2022194733A2 (en) 2022-09-22
WO2022194733A3 (en) 2022-11-10
JP2024510302A (ja) 2024-03-06
CN116997325B (zh) 2025-12-05

Similar Documents

Publication Publication Date Title
AR092470A1 (es) Formulaciones acuosas estables de adalimumab
BR0107811A (pt) Composição herbicida
BR112012021873B8 (pt) composição de matéria, artigo de manufatura, métodos para preparar uma composição, para aumentar a estabilidade de uma proteína em solução aquosa livre de polissorbato e para prevenir ou reduzir a agregação de uma proteína em solução aquosa livre de polissorbato
HRP20161771T4 (hr) Formulacije bendamustina
CL2020002252A1 (es) Formulación oftálmica.
AR094012A1 (es) Composiciones estables con peroxido para el cuidado oral
AR036248A1 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
AR037755A1 (es) Composiciones acuosas con contenido de metronidazol
EA200970377A1 (ru) Композиции фенилалкиламинокарбамата
MX373040B (es) Composicion farmaceutica acuosa liquida que contiene derivados de ciclodextrina eterificada con conservador.
EA202092926A2 (ru) Лиофилизированные составы, содержащие фактор ix
CY1122084T1 (el) Συνθεσεις που περιλαμβανουν αμλοδιπινη και μπισοπρολολη
CO6180423A2 (es) Forma farmaceutica que contiene metocarbamol, meloxicam y betametasona
JP2017514924A5 (cg-RX-API-DMAC7.html)
FI3817751T3 (fi) Vedettömän natriumtiosulfaatin formulaatioita
MX2022000623A (es) Composiciones y kits para una suspension de omeprazol.
NO20091492L (no) Fenylalkylkarbamatsammensetninger
UY39094A (es) Composición farmacéutica que comprende compuesto derivado de bencimidazol
MX2021014310A (es) Formulaciones de terlipressina.
BR112012030415A2 (pt) composições pesticidas
JOP20190156B1 (ar) أميدات عطرية لحمض الكربوكسيليك بصفتها مضادات لمستقبلة البراديكينين b1
EA200702593A1 (ru) Высококонцентрированные композиции, применимые для борьбы с экто- и эндопаразитами
CO2021014255A2 (es) Composiciones antifúngicas
BR112019006292A2 (pt) composições e métodos
WO2022194733A3 (en) Stable formulations of indocyanine green